|
DTNB expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.78690000018911E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.17460000024361E-07 |
| Normal-vs-Stage2 |
2.563800E-01 |
| Normal-vs-Stage3 |
4.3265000004844E-07 |
| Normal-vs-Stage4 |
9.18170000030472E-07 |
| Stage1-vs-Stage2 |
9.348500E-02 |
| Stage1-vs-Stage3 |
2.901000E-01 |
| Stage1-vs-Stage4 |
5.998400E-02 |
| Stage2-vs-Stage3 |
3.444400E-02 |
| Stage2-vs-Stage4 |
1.006130E-02 |
| Stage3-vs-Stage4 |
3.363200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.41850000001664E-06 |
| Normal-vs-AfricanAmerican |
3.856100E-02 |
| Normal-vs-Asian |
7.97130000000923E-05 |
| Caucasian-vs-AfricanAmerican |
7.724200E-01 |
| Caucasian-vs-Asian |
6.582800E-01 |
| AfricanAmerican-vs-Asian |
5.865600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.39850000024921E-07 |
| Normal-vs-Female |
1.68469999994869E-06 |
| Male-vs-Female |
9.241900E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.14509999999046E-06 |
| Normal-vs-Age(41-60Yrs) |
4.69510000000728E-06 |
| Normal-vs-Age(61-80Yrs) |
8.0351000000034E-05 |
| Normal-vs-Age(81-100Yrs) |
4.29280000002752E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.315200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.763400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.635600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.482600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.222400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.566300E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.916300E-02 |
| Classical-VS-Follicular |
2.256000E-03 |
| Classical-VS-Other |
6.968400E-01 |
| Classical-VS-Normal |
3.79640000547354E-08 |
| Tall-VS-Follicular |
2.164000E-04 |
| Tall-VS-Other |
6.101200E-01 |
| Tall-VS-Normal |
2.11759999535488E-08 |
| Follicular-VS-Other |
1.214990E-01 |
| Follicular-VS-Normal |
4.739700E-02 |
| Other-VS-Normal |
5.124700E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.184400E-04 |
| Normal-vs-N1 |
3.70560000000353E-05 |
| N0-vs-N1 |
3.758300E-02 |
|
|
